Nasdaq Most Active

Prism Marketview
  • Home
  • Indexes
    • All Indexes
    • Aerospace and Defense
    • AI Datacenter and Infrastructure
    • Biotech
    • Cannabis
    • Comms and Media
    • Consumer Products
    • Cybersecurity
    • Crypto Mining
    • EV
    • Fintech
    • Global Health
    • Healthcare
    • MedDevices
    • Mental Health
    • New Energy
    • NextGen Tech & AI
    • Oil & Gas
    • Pet Care
    • Pharmaceuticals
    • Precious Metals
    • Psychedelics
    • Semiconductors
    • Space
    • Sports
    • Weight Loss
    • Wellness
    • Women?s Health
  • Companies
  • Trending News
    • PRISM View
    • Biotech
    • Finance
    • Healthcare
    • Technology
    • Login
    • User Profile
    • Log Out
  • Home
  • Indexes
    • All Indexes
    • Aerospace and Defense
    • AI Datacenter and Infrastructure
    • Biotech
    • Cannabis
    • Comms and Media
    • Consumer Products
    • Cybersecurity
    • Crypto Mining
    • EV
    • Fintech
    • Global Health
    • Healthcare
    • MedDevices
    • Mental Health
    • New Energy
    • NextGen Tech & AI
    • Oil & Gas
    • Pet Care
    • Pharmaceuticals
    • Precious Metals
    • Psychedelics
    • Semiconductors
    • Space
    • Sports
    • Weight Loss
    • Wellness
    • Women?s Health
  • Companies
  • Trending News
    • PRISM View
    • Biotech
    • Finance
    • Healthcare
    • Technology
    • Login
    • User Profile
    • Log Out

Home News Feeds Finance Kalshi valuation jumps to $40 billion in latest funding round

Kalshi valuation jumps to $40 billion in latest funding round

October 29, 2026

The prediction market platform one year ago was valued at $5 billion.

Share this article:
This article was originally published here.

Finance News

  • Investors Prisom stocks chart

    How Nvidia turmoil and a Democratic Congress could reshape the AI trade, according to ETF experts

    November 14, 2026
  • "BioLife Solutions signs a multi-year agreement with Qkine Limited to distribute cytokine and growth factor products, enhancing its cell and gene therapy portfolio. Learn more about this strategic partnership."

    Fed’s Goolsbee calls inflation report ‘borderline disturbing’ as central bank weighs more hikes

    November 11, 2026
  • stock market investments smallcaps microcaps

    Berkshire Hathaway more than doubles buybacks in third quarter as earnings decline

    November 07, 2026
  • Top Democrats call to rein in AI buildout after midterms sweep: ‘National data center moratorium now’

    November 05, 2026
  • #stockmarkets #investor news #smallcaps #microcaps

    What the Democratic midterms sweep changes for U.S.-China relations

    November 05, 2026
  • Texas governor race tightens in prediction markets, but Abbott remains favored

    November 02, 2026
View All

News

  • Latest
  • PRISM View
  • Biotech
  • Finance
  • Healthcare
  • Technology

Indexes

  • Aerospace & Defense
  • AI Datacenter and Infrastructure
  • Biotech
  • Cannabis
  • Comms and Media
  • Consumer Products
  • Crypto Mining
  • Cybersecurity
  • EV
  • Fintech
  • Global Health
  • Healthcare
  • MedDevices
  • Mental Health
  • New Energy
  • NextGen Tech & AI
  • Oil & Gas
  • Pet Care
  • Pharmaceuticals
  • Psychedelics
  • Semiconductors
  • Space
  • Sports
  • Weight Loss
  • Wellness
  • Women’s Health
  • Home
  • About Us
  • Contact Us

Copyright © 2026 PRISM MarketView. All rights reserved.

  • Terms & Conditions
  • Privacy Policy
  • Disclaimer